Twenty-one HUB genes with a significant influence on ESCC progression were identified, and five of these genes (CPP1, BGN, SPARC, POSTN and Cd1A2) were identified as having a high expression level associated with poor disease-free survival for ESCC patients [48]. The gene discussed is ELAVL2; the disease is esophageal squamous cell carcinoma.